Dermal Therapy Chafing & Sweat Rash Prevention Cream 75g

SKU: 20022084

In-store pricing may vary by store. Triple action formula for long-lasting protection against sweat rash.

Read More
$16.99
4 x $4.25 with
Available For Click & Collect
Available For Delivery

Delivery Only Or Purchase In-Store
Not Available For Click & Collect

Available for Click & Collect Only
Not Available For Delivery

Available for Purchase In-Store Only

Delivery_Stamp_1d12b3a0-3503-4eb2-8782-7011e0d86c35 Delivery_Stamp_1d12b3a0-3503-4eb2-8782-7011e0d86c35

You will earn 17 Living Rewards points per item with this purchase Login or Sign Up

Sorry, this item is not available for purchase
  • Dermal Therapy’s Chafing & Sweat Rash Prevention Cream is a triple action formula for long-lasting protection. -48 hour sweat protection -Lubricates to protect the skin -Fragrance free

    Triple action formula for long-lasting protection against sweat rash.


  • To prevent chafing and sweat rash, apply cream to clean, dry skin once or twice daily. Apply to specified body areas that are prone to perspiration and chafing between skin surfaces.

  • Aqua; Aluminum Zirconium Octachlorohydrex GLY; Paraffinum Liquidum; Petrolatum; Propylene Glycol; Lanolin; Cetearyl Alcohol; Cetyl Alcohol; Sorbitan Stearate; Glyceryl Stearate; PEG-100 Stearate; Polyquaternium-37, Polymethylsilsesquioxane/Silica Crosspolymer; Panthenol; Benzyl Alcohol; Dehydroacetic Acid; Glycerin; Hydroxyacetophenone; Sodium Hydroxide

  • This product has a purchase limit of 0. If the limit is 0, there is no restriction on the quantity you can purchase.

Care & Advice Health Hub
Our new Care & Advice Health Hub offers a wide range of essential services, from general health checks to specialised consultations.
Dont miss these bargains!
50% off Select Oral B, Buy 1 Get 1 50% off Clinicians, Maybelline and more!
06410_-_Flu_campaign_-_Web_Life_3x1_specials_card_880x880_f3018824-2b68-472b-b7de-d874adbd8acd
Protect against the Flu this season!
Choose from three different Flu Vaccinations in 2025.